Tag: cancer study analysis

Categories
Anti Cancer Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment Claims & Critical Analysis Cancer Treatment Options Cancer Wellness Protocols Clinical Trials & Cancer Treatment Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Health & Wellness Hulscher Study Ivermectin Mebendazole Non-Chemo Cancer Treatments Repurposed Drug Studies Research & Science Wellness Company

The Wellness Company Study of Ivermectin and Mebendazole Review

Hulscher cohort study of Ivermectin and Mebendazole

A study conducted by Dr. Nicolas Hulscher at the Wellness Company examined the effects of compounded Ivermectin and Menebedazole on 197 cancer patients over six months. While results appear promising, concerns arise regarding the study’s methodology, raising questions about the necessity of formal clinical trials for FDA consideration.

Categories
Anti Cancer cancer research Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Guidance Cluster Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Health & Wellness Hulscher Study Ivermectin Mebendazole

What is an ‘expression of concern’ from a scientific Hulscher 2026 ivermectin study financially connected to The Wellness Company?

An expression of concern (EOC) is a warning from a journal about potential issues in a study’s integrity without retracting it. Anticancer Research issued an EOC for Hulscher et al. (2026), citing data verifiability and ethical concerns, particularly due to conflicts of interest and reliance on self-reported outcomes without rigorous controls.